However, as AD progresses, the fundamental abnormality that could eventually limit therapeutic efficacy of trophic factor administration is progressive brain insulin and IGF resistance, or reduced ability to respond to trophic factor stimulation [16]. Here, IGF1 is linked to Alzheimer disease.